Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CyclinE1/CDK2 inhibitors
CyclinE1/CDK2 inhibitors
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
BioSpace
Thu, 06/1/23 - 06:43 pm
Bayer
Cedilla Therapeutics
CyclinE1/CDK2 inhibitors
oncology
precision oncology